PubMed

Quantification of angiogenesis in estrogen receptor-positive and negative breast carcinoma.

Parentes-Vieira J, Lopes-Costa P, Pires C, Dos Santos A, Pereira-Filho J, da Silva B.

Int Semin Surg Oncol. 2007 Aug 24;4:22.PMID: 17718911 [PubMed - in process]Free PMC ArticleFree textRelated citations

Bcl-2 oncogene expression in estrogen receptor-positive and negative breast carcinoma.

dos Santos LG, Lopes-Costa PV, dos Santos AR, Facina G, da Silva BB.

Eur J Gynaecol Oncol. 2008;29(5):459-61.PMID: 19051812 [PubMed - indexed for MEDLINE]Related citations

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.

Cancer. 2008 Mar 1;112(5):995-1000.PMID: 18098228 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Effects of raloxifene on Ki-67 and CD34 antigen expression in breast cancer.

da Silva BB, Pires CG, dos Santos AR, de Castro-Leão AH, Alencar AP, Lopes-Costa PV.

Gynecol Obstet Invest. 2009;67(2):103-8. Epub 2008 Oct 27.PMID: 18953168 [PubMed - indexed for MEDLINE]Related citations

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.

Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA.

Breast Cancer Res. 2008;10(5):R85. Epub 2008 Oct 15. Erratum in: Breast Cancer Res. 2009;11(1):401. PMID: 18922159 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Mast cell and macrophage counts and microvessel density in invasive breast carcinoma-comparison analysis with clinicopathological parameters.

Kwon GY, Lee SD, Park ES.

Cancer Res Treat. 2005 Apr;37(2):103-8. Epub 2005 Apr 30.PMID: 19956488 [PubMed]Free PMC ArticleFree textRelated citations

Quantification of angiogenesis induced in rabbit cornea by breast carcinoma of women treated with tamoxifen.

da Silva BB, da Silva Júnior RG, Borges US, da Silveira Filho MA, Pimentel IC, Gebrim LH, Simões Mde J, Baracat EC.

J Surg Oncol. 2005 May 1;90(2):77-80.PMID: 15844191 [PubMed - indexed for MEDLINE]Related citations

Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.

El Sharkawy SL, Farrag AR.

Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):108-12.PMID: 18227734 [PubMed - indexed for MEDLINE]Related citations

Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.

Safwat MD, Habib F, Elayat A, Oweiss N, Reffat S, Algaidi S.

Folia Morphol (Warsz). 2009 Aug;68(3):144-55.PMID: 19722158 [PubMed - indexed for MEDLINE]Related citations

Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.

Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P.

Hum Pathol. 2008 Dec;39(12):1809-15. Epub 2008 Aug 19.PMID: 18715613 [PubMed - indexed for MEDLINE]Related citations

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

Novelli F, Milella M, Melucci E, Di Benedetto A, Sperduti I, Perrone-Donnorso R, Perracchio L, Venturo I, Nisticò C, Fabi A, Buglioni S, Natali PG, Mottolese M.

Breast Cancer Res. 2008;10(5):R74. Epub 2008 Sep 4.PMID: 18771580 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

[Nuclear morphometry and estrogen receptors in infiltrating ductal carcinoma of the breast]

Giardina C, Serio G, Simone G, Pennella A, Vacca E, Ricco R, Scordari D, Pesce Delfino V.

Boll Soc Ital Biol Sper. 1990 Feb;66(2):135-41. Italian. PMID: 2162679 [PubMed - indexed for MEDLINE]Related citations

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

Sunami E, Shinozaki M, Sim MS, Nguyen SL, Vu AT, Giuliano AE, Hoon DS.

Breast Cancer Res. 2008;10(3):R46. Epub 2008 May 16.PMID: 18485221 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO.

J Clin Oncol. 2007 Oct 20;25(30):4772-8. Epub 2007 Sep 17.PMID: 17876012 [PubMed - indexed for MEDLINE]Related citations

Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.

Christgen M, Christgen H, Heil C, Krech T, Länger F, Kreipe H, Lehmann U.

Cancer Sci. 2009 Sep;100(9):1767-71. Epub 2009 May 27.PMID: 19549254 [PubMed - indexed for MEDLINE]Related citations

Prognostic significance of molecular classification of breast invasive ductal carcinoma.

Muñoz M, Fernández-Aceñero MJ, Martín S, Schneider J.

Arch Gynecol Obstet. 2009 Jul;280(1):43-8. Epub 2008 Dec 11.PMID: 19082617 [PubMed - indexed for MEDLINE]Related citations

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F.

J Clin Oncol. 2008 Mar 10;26(8):1260-8.PMID: 18323549 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. Epub 2008 Jan 25.PMID: 18296077 [PubMed - indexed for MEDLINE]Related citations

Estrogen receptor and breast MR imaging features: a correlation study.

Chen JH, Baek HM, Nalcioglu O, Su MY.

J Magn Reson Imaging. 2008 Apr;27(4):825-33.PMID: 18383260 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.PMID: 19256737 [PubMed - indexed for MEDLINE]Related citations